A new breakthrough in microfluidics could lead to autonomous blood analysis chips that will be able to diagnose diseases in mere minutes. [Image: UC Berkeley] The device, called SIMBAS, was developed ...

A new biochip-based blood test can help identify patients at a higher risk for Alzheimer’s disease just as accurately as the standard molecular diagnostic test. Researchers from Randox Laboratories ...

Archer Materials is making strides in advancing its Biochip technology, focusing on improving the accuracy of graphene field effect transistor sensors for blood potassium testing, crucial for chronic ...

febit's microfluidic microarray technology offers a promising approach for diagnostic testing based on automated microRNA (miRNA) biomarker profiling. The Geniom RT Analyzer makes it possible to ...

Archer Materials Limited (“Archer”, the “Company”), a semiconductor company advancing the quantum computing and medical diagnostics industries, has developed a next generation biochip fabrication to ...

A new “biochip” under development to accurately identify disease strains may reduce costs for medical testing and also reduce wait time for results. The Hydra-1K — which is a silicon chip — can be ...

Archer Materials has announced the commencement of development for its lab-on-a-chip device, the A1 Biochip. "Archer has made a step-change in advancing its graphene-based biosensor technology ...